ClinicalTrials.gg
Sign In

Hyperlipidemias clinical trials

The registry lists 861 studies for Hyperlipidemias across more than 10 countries. 110 are recruiting or about to start. 362 of them are mainly about Hyperlipidemias (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 7 narrower conditions too, such as Hypercholesterolemia: 2,409 studies, 272 open.

ClinicalTrials.gov finds 2,430 studies for Hyperlipidemias. How that becomes 861 here

This page counts the studies the registry files under Hyperlipidemias, and those it files under no condition that list Hyperlipidemiasthemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 2,430Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −1,479Filed under a narrower condition, counted on its own pageHypercholesterolemia 993 · Hypertriglyceridemia 256 · Hyperlipoproteinemia Type II 155 · Homozygous Familial Hypercholesterolemia 38 · Hyperlipoproteinemias 16 · Hyperlipoproteinemia Type I 13 · 1 more
  3. −5List Hyperlipidemias as a condition, but the registry did not file them under itMost often written as “Hyperlipemia, Carbohydrate Inducible” (1), “Carbohydrate Inducible Hyperlipemia” (1), and “Hyperlipidemia in Children” (1). The registry filed them under other conditions only, most often Hyperlipoproteinemia Type IV (2) and Hyperlipoproteinemia Type V (2).
  4. −85Match it another way28 name it in the title, 5 in a keyword, and 52 by a synonym or other text the search reads.
  5. 861The count on this page15 of them list Hyperlipidemias in their own words; the registry filed them under no condition.

Get an email when these change. Save the Hyperlipidemias studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
596
Status unknown
82
Recruiting
68
Not yet recruiting
33
Terminated
33
Active, not recruiting
22

Phase

Phase 3
171
Phase 1
117
Phase 2
113
Phase 4
73
Early Phase 1
9

Where

United States
338
Canada
94
China
93
Korea, Republic of
79
Taiwan
40
United Kingdom
40

Who runs them

Pfizer (27) · Takeda (21) · AstraZeneca (20) · Amgen (17) · Novartis Pharmaceuticals (13) · University Health Network, Toronto (11) · University of Toronto (9) · Esperion Therapeutics, Inc. (9)

What is being tested here

Drugs under test in Hyperlipidemias studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Inclisiran5711
Rosuvastatin1728
Simvastatin11014
Bempedoic acid168
HRS-1301105
Colesevelam115
HRS-7249103
Enlicitide122
SHR-1918112
Berberine111

Drug classes tested here Statins 3 open · PCSK9 inhibitors 24 · Angiotensin receptor blockers (ARBs) 12 · Calcium channel blockers 7

Coming up

19phase 3 studies under way
41studies finish main data collection within a year8 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 68 Hyperlipidemias studies recruiting now, 28 (41%) set no upper age limit and 32 (47%) stop at 75 or younger. 8 (12%) take children under 18. 2 (3%) are for women only and 2 (3%) for men only; 16 (24%) take healthy volunteers.

Recruiting studies that take each age, of 68
AgeWomenMen
105 (7%)5 (7%)
1844 (65%)45 (66%)
3053 (78%)53 (78%)
4058 (85%)58 (85%)
5059 (87%)59 (87%)
6553 (78%)53 (78%)
7542 (62%)42 (62%)
8529 (43%)30 (44%)

Across all 861 studies, recruiting or not: 47% stop at 75 or younger and 29% at 65; 6% take children; 3% are for women only and 7% for men only; 36% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Hyperlipidemias studies take

Of 57 phase 3 interventional studies under Hyperlipidemias, half reached primary completion within 18 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 13 mo1–10 · 54 studies3 mo1–10 · 47 studies—
Phase 216 mo10–27 · 30 studies——
Phase 318 mo11–32 · 57 studies18 mo10–26 · 51 studies—
Phase 428 mo16–44 · 18 studies——
Interventional, no phase15 mo7–31 · 171 studies—16 mo7–31 · 166 studies
Observational28 mo11–68 · 35 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Started recruiting2

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 861. Browse all 861 → or search them.